Vetsource Data Highlights Declining Veterinary Visits Amid Revenue Growth

According to a recent LinkedIn post from Vetsource, the company’s latest white paper suggests that veterinary visits declined 3.1% in 2025, extending a three‑year downward trend. The post indicates that, despite this drop in visit volume, veterinary practice revenue is rising, driven primarily by higher per‑visit pricing.

The LinkedIn post implies that this dynamic may be masking an underlying weakness in client traffic and overall demand. It further suggests that veterinary practices focusing solely on price increases may face long‑term growth constraints if they do not address client retention and visit frequency.

For investors tracking the veterinary and animal‑health ecosystem, the data points highlighted by Vetsource could signal a maturing market where volume growth is slowing. This environment may favor companies offering retention, analytics, and practice‑management tools, since practices may seek data‑driven solutions to stabilize or grow client visits.

The emphasis on retention and analytics in the post positions Vetsource as a potential beneficiary of this shift in practice priorities. If practices increasingly adopt platforms that help manage client relationships and optimize pricing and communication, Vetsource’s solutions suite could see higher demand and potentially stronger recurring revenue over time.

At the same time, sustained declines in visit volume could pressure certain product categories tied directly to in‑clinic activity, such as some diagnostics or procedure‑dependent services. Investors may want to monitor whether the trends cited in Vetsource’s white paper are cyclical or structural, and how quickly practices adapt their business models in response.

The post also directs readers to download the full white paper, indicating that Vetsource is leveraging proprietary data to strengthen its role as an insights provider to veterinary practices. This analytics positioning may enhance the company’s competitive differentiation and support premium pricing for its platforms if the data prove actionable for practice growth.